Pfizer has conducted a SWOT analysis to assess its current market position as it approaches a critical phase known as the patent cliff. The analysis highlights the company's strengths, weaknesses, opportunities, and threats, particularly in relation to its portfolio of new drugs designed to offset the impact of expiring patents on existing products. This strategic evaluation aims to ensure that Pfizer remains competitive and continues to deliver value to its shareholders amidst changing market dynamics. The findings from the analysis are expected to guide the company's future decisions and investments in research and development.
Don't miss out on breaking stories and in-depth articles.
